[PERSON]
Naveed Sattar
Featured in 3 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
290 clusters · 1094 sources · last updated
Latest: GLP-1 weight loss medications transform obesity treatment paradigm
Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. Research suggests secondary benefits, including a 21% lower risk of fragility fr
Type 2 diabetes remission and complication research
2 clusters · 5 sources · last updated
Latest: Diabetes research highlights kidney disease risks and remission potential
Research into type 2 diabetes has focused on the mechanisms of remission and the associated risks of long-term complications. Remission is defined as maintaining an A1c level below 6.5% for at least three consecutive mon
Links between diabetes, obesity, and cancer risk
3 clusters · 12 sources · last updated
Latest: Type 2 diabetes linked to double cancer risk
Scientific research continues to establish strong connections between type 2 diabetes, obesity, and increased risks for cancer and organ failure. New data published in the British Medical Journal clarifies the impact of